Jim Simons - Renaissance Technologies LLC 13F Activity & Position Changes (Q4 2025)

As of Dec 31, 2025, the Renaissance Technologies LLC portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Feb 12, 2026. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q4 2025, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q4 2025
00183L201
ANGI
Sell
-531,342
Q4 2025
04681Y103
Ategrity
Sell
-448
Q4 2025
27616P301
Easterly Government
Sell
-13,466
Q4 2025
40090E106
Grupo Cibest
Sell
-164,700
Q4 2025
433313103
Hinge Health
Buy
+344,700
Q4 2025
55318A108
MNTN
Buy
+338,189
Q4 2025
573134103
Marti Technologies
Buy
+7,444
Q4 2025
62548M209
Claritev
Sell
-39,148
Q4 2025
690145206
Outset Medical
Buy
+4,745
Q4 2025
741623102
Primo Brands
Sell - Position Exit
-704,519
Q4 2025
85423L103
StandardAero
Sell
-569,300
Q4 2025
87318A101
TWFG
Buy
+2,900
Q4 2025
AA
Alcoa Corporation
Sell - Position Exit
-81,296
Q4 2025
AAAU
Goldman Sachs Physical Gold ETF
Sell
-56,300
Q4 2025
AADI
Aadi Bioscience, Inc.
Sell
-16,700
Q4 2025
AAL
American Airlines Group, Inc.
Sell
-1,264,200
Q4 2025
AAME
Atlantic American Corporation
Buy
+3,819
Q4 2025
AAP
Advance Auto Parts Inc.
Buy
+129,900
Q4 2025
AAPL
Apple Inc.
Sell - Position Exit
-3,125
Q4 2025
AAT
American Assets Trust, Inc.
Buy
+16,400
Q4 2025
AAXJ
iShares MSCI All Country Asia e
Buy - Position Entry
+48,318
Q4 2025
ABBV
AbbVie Inc.
Sell - Position Exit
-928,071
Q4 2025
ABCB
Ameris Bancorp
Sell
-7,200
Q4 2025
ABCL
AbCellera Biologics Inc.
Sell
-971,500
Q4 2025
ABEO
Abeona Therapeutics Inc.
Sell
-410,237
Q4 2025
ABEV
Ambev S.A.
Sell
-15,974,400
Q4 2025
ABL
Abacus Life, Inc.
Sell
-166,900
Q4 2025
ABNB
Airbnb, Inc.
Buy
+437,789
Q4 2025
ABOS
Acumen Pharmaceuticals, Inc.
Sell
-161,192
Q4 2025
ABT
Abbott Laboratories
Buy - Position Entry
+558,066
Page 1 of 113